Tasley Pharma is a Tianjin, China-based listed pharmaceuticals company that acts as a strategic corporate investor for life sciences companies tied to China. It has acted as a lead investor in later-stage drug development financing and is most relevant to pharmaceutical, biotechnology and life sciences businesses, including advanced therapies and therapeutic areas such as cardiometabolism, digestive disorders and neurology.